Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation

Molecular and Cellular Biology

Volumn 16, Issue 4, 1996, Pages 1604-1613

  Johnson, Sally E ^a   Wang, Xueyan ^a   Hardy, Serge ^a,b   Taparowsky, Elizabeth J ^a   Konieczny, Stephen F ^a  

^a PURDUE UNIVERSITY   (United States)

^b Lab de Biol et Genet du Devmt   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; MYOD PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 0029995310     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.4.1604     Document Type: Article

References (45)

1. Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev 6:166-176.
2. Blackwell, T. K., and H. Weintraub. 1990 Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110
3. Bousset, K., M. Henriksson, J. M. Luscher-Firzlaff, D. W. Litchfield, and B. Luscher. 1993 Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 8:3211-3220.
4. Brennan, T. J., and E. N. Olson. 1990. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization Genes Dev 4:582-595.
5. Davis, R. L., P. F. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation Cell 60:733-746.
6. Davis, R. L., and H. Weintraub. 1992. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 256:1027-1030.
7. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
8. Fairman, R., R. K. Beran-Steed, S. J. Anthony-Cahill, J. D. Lear, W. F. Stafford, W. F. DeGrado, P. A. Benfield, and S. L. Brenner. 1993. Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptides. Proc. Natl. Acad. Sci. USA 90:10429-10433.
9. Genetta, T., D. Ruezinsky, and T. Kadesch. 1994. Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol. Cell Biol. 14:6153-6163.
10. Hardy, S., Y. Kong, and S. F. Konieczny. 1993. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol. Cell Biol. 13:5943-5956.
11. Harrison-Heller, R. A., and M. P. Czech. 1991. Enhanced casein kinase II activity in COS-1 cells upon over-expression of either its catalytic or non-catalytic subunit. J. Biol Chem. 266:14435-14439.
12. Hu, J.-S., E. N. Olson, and R. E. Kingston. 1992. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol. 12:1031-1042.
13. Jen, Y., H. Weintraub, and R. Benezra. 1992. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev 6:1466-1479.
14. Karin, M., and T. Smeal. 1992. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17:418-422.
15. val inhibits myogenesis without altering the DNA binding or transcriptional activities of the muscle regulatory factors. Mol. Cell. Biol. 15:5205-5213.
16. Kong, Y., and S. Konieczny. Unpublished data.
17. Lassar, A., and A. Munsterberg. 1994. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr. Biol. 6:432-442.
18. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991 Functional activity of myogenic HLH proteins requires hetero-oligomerization with an K12/E47-like protein in vivo. Cell 66:305-315.
19. Lassar, A. B., M. J. Thayer, R. W. Overall, and H. Weintraub. 1989 Transformation by activated Ras or Fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58:659-667.
20. Li, L., R. Heller-Harrison, M. Czech, and E. N. Olson. 1992. cAMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins Mol. Cell Biol. 12:4478-4485.
21. Li, L., J. Zhou, G. James, R. Heller-Harrison, M. P. Czech, and E. N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194.
22. Lin, A., J. Frost, T. Deng, T. Smeal, N. Al-Alawi, U. Kikkawa, T. Hunter, D. Brenner, and M. Karin. 1992. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 70:777-789.
23. Lin, H., K. E. Yutzey, and S. F. Konieczny. 1991 Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors. Mol. Cell. Biol. 11: 267-280.
24. Ludolph, D. C., and S. F. Konieczny. 1995. Transcription factor families: muscling in on the myogenic program FASEB J 9:1595-1604
25. Ma, P. C. M., M. A. Rould, H. Weintraub, and C. O. Pabo. 1994. Crystal structure of MyoD bHLH domain-DNA complex. perspectives on DNA recognition and implications for transcription. Cell 77:451-459.
26. Mitsui, K., M. Shirakata, and B. M. Paterson. 1993. Phosphorylation inhibits the DNA-binding activity of MyoD homodimers but not MyoD-E12 heterodimers. J. Biol. Chem. 268:24415-24420
27. Miwa, T., and L. Kedes. 1987. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human α-cardiac actin gene. Mol. Cell. Biol. 7:2803-2813.
28. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
29. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, N. Y. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
30. Neuhold, L., and B. Wold. 1993. HLH forced dimers: tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id Cell 74:1033-1042
31. Olson, E. N., and W. H. Klein. 1994. bHLH factors in muscle development: deadlines and commitments, what to leave in and what to leave out Genes Dev. 8:1-8.
32. Pesce, S., and R. Benezra. 1993. The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Mol. Cell. Biol. 13:7874-7880.
33. Ruezinsky, D., H. Beckmann, and T. Kadesch. 1991. Modulation of the IgH enhancer's cell type specificity through a genetic switch Genes Dev. 5:29-37.
34. Shen, C. P., and T. Kadesch. 1995 B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15:4518-4524.
35. Shirakata, M., F. K. Friedman, Q. Wei, and B. M. Paterson. 1993. Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues. Genes Dev 7:2456-2470.
36. Sloan, S., C. P. Shen, and T. Kadesch. B cell specific activity of E47 homodimers is determined by differential phosphorylation. Submitted for publication.
37. Stigare, J., N. Buddelmeijer, A. Pigon, and E. Egyhazi. 1993. A majority of casein kinase II alpha subunits is tightly hound to intranuclear components but not to the beta subunit. Mol. Cell. Biochem. 129:77-85.
38. Sun, X.-H., and D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64:459-470.
39. Tapscott, S. J., R. L. Davis, M. J. Thayer, P. F. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
40. Weintraub, H., V. J. Dwarki, I. Verman, R. Davis, H. Hullenberg, L. Snider, A. Lassar, and S. J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5:1377-1386.
41. Weintraub, H., T. Genetta, and T. Kadesch. 1994. Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements. Genes Dev. 8:2203-2211.
42. Winter, B., and H. Arnold. Personal communication.
43. Winter, B., T. Braun, and H. H. Arnold. 1993 cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD J. Biol. Chem. 268:9869-9878.
44. Wright, W., M. Binder, and W. Funk. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104-4110.
45. Yutzey, K. E., and S. F. Konieczny. 1992 Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer. Nucleic Acids Res 20:5105-5113.